The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that a growing share of company's revenue now arrives without a new selling event (reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket/consumable pull-through, customers' own routines) AND that this self-arriving share has recently and visibly grown as proportion of business, with management grounding shift in observed current behavior and treating as changing quality of revenue? We need use only transcript. Company Agios, TIBSOVO launch, IDHIFA. Revenue from product sales. Need see if management describes recurring revenue? This is pharma, prescriptions. They discuss launch, prescribers, testing rates, duration. But question about self-arriving revenue without new selling event? In pharma, repeat prescriptions? They mention treatment duration, patients continue therapy. But is there a "growing share of revenue now arrives without a new selling event" and "recently and visibly grown as proportion"? Management discusses TIBSOVO launch, initial patients, duration expected to increase. But not explicitly about reorders/refills. They talk about payer mix, inventory. No mention of recurring revenue or repeat purchases. They mention "treatment duration" expected to increase as launch progresses and patient mix evolves. But that's future expectation, not observed current behavior. Also IDHIFA duration consistent with previously reported. No concrete grounding in recent period of self-arriving revenue. So answer NO. Need ensure no hidden. They discuss "initial patients treated with TIBSOVO will be more advanced... as launch progresses and patient mix evolves, duration increase." That's planned/hoped. Not observed. Also "over 100 unique prescribers" etc. No. Thus NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.